Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
Vincent
H H
HH
Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Wenting
G J
GJ
Jeekel
J
J
Schalekamp
M A
MA
Weimar
W
W
D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use
D003524:Cyclosporins; D004088:Dihydroergotoxine; D011241:Prednisone; D006854:Hydrocortisone